Phase 1 7 trials
Phase 1
NCT05279001 Jul 2024 → May 2025 myelofibrosis Suzhou Zelgen Biopharmaceuticals Co.,Ltd
Unknown
No outcome recorded
Phase 1
NCT06193148 Mar → Jun 2024 —
Suzhou Zelgen Biopharmaceuticals Co.,Ltd
Completed
No outcome recorded
Phase 1
NCT06132243 Nov → Dec 2023 myelofibrosis Suzhou Zelgen Biopharmaceuticals Co.,Ltd
Completed
No outcome recorded
Phase 1
NCT05150717 Jan 2022 —
Suzhou Zelgen Biopharmaceuticals Co.,Ltd
Completed
No outcome recorded
Phase 1
NCT06246695 Oct 2021 → Jan 2022 —
Suzhou Zelgen Biopharmaceuticals Co.,Ltd
Completed
No outcome recorded
Phase 1
NCT04993404 Aug 2021 → Sep 2022 liver disorder Suzhou Zelgen Biopharmaceuticals Co.,Ltd
Completed
No outcome recorded
Phase 1
NCT03314402 Sep 2017 → Aug 2018 —
Suzhou Zelgen Biopharmaceuticals Co.,Ltd
Completed
No outcome recorded
Phase 1/2 3 trials
Phase 1/2
NCT04866056 Sep 2021 → Jun 2022 myelodysplastic syndrome , myelofibrosis Suzhou Zelgen Biopharmaceuticals Co.,Ltd
Terminated
No outcome recorded
Phase 1/2
NCT04435392 Oct 2020 → Sep 2022 atopic eczema Suzhou Zelgen Biopharmaceuticals Co.,Ltd
Completed
No outcome recorded
Phase 1/2
NCT04445363 Aug 2020 → Dec 2024 alopecia areata Suzhou Zelgen Biopharmaceuticals Co.,Ltd
Unknown
No outcome recorded
Phase 2 13 trials
Phase 2
NCT04971551 Dec 2024 → Jun 2025 acute graft versus host disease Suzhou Zelgen Biopharmaceuticals Co.,Ltd
Unknown
No outcome recorded
Phase 2
NCT05688839 Apr 2024 → Feb 2025 COVID-19 Suzhou Zelgen Biopharmaceuticals Co.,Ltd
Unknown
No outcome recorded
Phase 2
NCT05686629 Apr 2024 → Feb 2025 COVID-19 Suzhou Zelgen Biopharmaceuticals Co.,Ltd
Unknown
No outcome recorded
Phase 2
NCT05672888 Mar 2023 → Jan 2024 pneumonia First Affiliated Hospital of Zhejiang University
Unknown
No outcome recorded
Phase 2
NCT05702788 Sep 2022 → Apr 2024 COVID-19 , pneumonia Suzhou Zelgen Biopharmaceuticals Co.,Ltd
Withdrawn
No outcome recorded
Phase 2
NCT04851535 Jul 2021 → Nov 2022 myelofibrosis Suzhou Zelgen Biopharmaceuticals Co.,Ltd
Completed
No outcome recorded
Phase 2
NCT04612699 Mar 2021 → Aug 2022 psoriasis Suzhou Zelgen Biopharmaceuticals Co.,Ltd
Completed
No outcome recorded
Phase 2
NCT04539639 Dec 2020 → May 2022 atopic eczema Suzhou Zelgen Biopharmaceuticals Co.,Ltd
Completed
No outcome recorded
Phase 2
NCT04507659 Dec 2020 → Aug 2022 ankylosing spondylitis Suzhou Zelgen Biopharmaceuticals Co.,Ltd
Completed
No outcome recorded
Phase 2
NCT04312594 Sep 2020 → Jun 2022 idiopathic pulmonary fibrosis Suzhou Zelgen Biopharmaceuticals Co.,Ltd
Completed
No outcome recorded
Phase 2
NCT04217993 Jan 2020 → Aug 2022 myelofibrosis , primary myelofibrosis Suzhou Zelgen Biopharmaceuticals Co.,Ltd
Completed
No outcome recorded
Phase 2
NCT04034134 Nov 2019 → Nov 2021 alopecia areata Suzhou Zelgen Biopharmaceuticals Co.,Ltd
Completed
No outcome recorded
Phase 2
NCT03886415 Jan 2019 → Feb 2021 myelofibrosis Suzhou Zelgen Biopharmaceuticals Co.,Ltd
Completed
No outcome recorded
Show 3 more trials Phase 3 7 trials
Phase 3
NCT05861128 Nov 2023 → Dec 2025 ankylosing spondylitis Suzhou Zelgen Biopharmaceuticals Co.,Ltd
Unknown
No outcome recorded
Phase 3
NCT05861102 Jul 2023 → May 2026 overdue ankylosing spondylitis Suzhou Zelgen Biopharmaceuticals Co.,Ltd
Active not recruiting
No outcome recorded
Phase 3
NCT05676242 Jan 2023 → Dec 2024 atopic eczema Suzhou Zelgen Biopharmaceuticals Co.,Ltd
Unknown
No outcome recorded
Phase 3
NCT05526222 Jul 2022 → Jun 2026 overdue atopic eczema Suzhou Zelgen Biopharmaceuticals Co.,Ltd
Active not recruiting
No outcome recorded
Phase 3
NCT05255237 Mar 2022 → Jun 2024 alopecia areata Suzhou Zelgen Biopharmaceuticals Co.,Ltd
Completed
No outcome recorded
Phase 3
NCT05051761 Sep 2021 → Dec 2023 alopecia areata Suzhou Zelgen Biopharmaceuticals Co.,Ltd
Completed
No outcome recorded
Phase 3
NCT04617028 Feb 2021 → Oct 2023 myelofibrosis Suzhou Zelgen Biopharmaceuticals Co.,Ltd
Completed
No outcome recorded